Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
Dr Reddy’s announces launch of Colchicine Tablets USP in the US
It is available in 0.6 mg tablets in bottle count sizes of 30s and 100s
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS,…
Dr Reddy’s PAT up 76 per cent in Q4, soft-launches HCQ in India
The performance was backed by tax deferment and growth in global generics, Dr Reddy's said
Dr Reddy’s recalls its heart burn medicine in the US
The move comes after US FDA found quality issues like ‘discolouration’ and presence of brown pellets in the company’s 40 mg…
Dr Reddy’s gets EIR from USFDA for Srikakulam plant
All facilities under warning letter are now determined as ‘voluntary action indicated’
Dr Reddy’s launches generic lipid-regulating tablets in US
The product is a generic version of AbbVie Inc's Tricor tablets
Dr Reddy’s launches generic opioid antagonist injection in US
The product is a generic version of ADAPT Pharma Operations's Narcan injection
Dr Reddy’s launches generic Ziprasidone Mesylate for injection in US
The product is a generic version of Pfizer's Geodon injection, 20 mg/mL
Satish Reddy elected CII SR Chairman
CK Ranganathan will be the deputy
The Chairman of Hyderabad-based Dr Reddy's Laboratories Satish Reddy has been elected…